Back to Capital World Investors Capital World Investors

ADAPYADAPY
12 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

Capital World Investors previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2022-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$27.3M

Total Shares Change

-6.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q1
Latest
Exited
0
-100.0%
$00.0%$2.06
0
2021-Q4
Unchanged
8M
0.0%
$30M0.0%$3.87
0
2021-Q3
Unchanged
8M
0.0%
$41.4M0.0%$5.20
0
2021-Q2
Unchanged
8M
0.0%
$34.1M0.0%$4.39
0
2021-Q1
Unchanged
8M
0.0%
$42.5M0.0%$5.05
0
2020-Q4
Unchanged
8M
0.0%
$43.1M0.0%$5.41
0
2020-Q3
Unchanged
8M
0.0%
$63.9M0.0%$7.66
0
2020-Q2
Unchanged
8M
0.0%
$80.1M0.0%$9.29
0
2020-Q1
Increased
8M
+17.8%
$21.8M0.0%$2.75
33
2019-Q4
Unchanged
6.8M
0.0%
$8.2M0.0%$1.16
0
2019-Q3
Unchanged
6.8M
0.0%
$10.3M0.0%$1.47
0
2019-Q2
New
6.8M
-
$27.3M0.0%$4.02
40

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used